好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Stroke Simulation Enhances Resident's Confidence in Acute Stroke/TIA Management
Neurologic 好色先生
P05 - (-)
003
BACKGROUND: AS management is time dependent and obviously frightening for new residents,ways to overcome this apprehension needs to be looked at.
DESIGN/METHODS: Between 2010-2012, a total of 9 neurology residents participated in AS simulation by the end of PGY-1 year before starting stroke calls. Four different case scenarios using standardized patients were used - TIA, Intraparenchymal hemorrhage, acute ischemic stroke within 3 hours (1st case) and within eight hours (4th Case) over 60 days with set time limit for each encounter. The simulation was video & audio taped. Historic controls consisting of PGY2 residents without simulation were used. Pre & post simulation survey, SP comments and debriefing was done for each scenario.
RESULTS: Residents reported 100 % satisfaction with quality of demonstrations and hands-on learning experience. The accuracy and timing of decision making-IV thrombolytic, No Thrombolytic or catheter based reperfusion was significantly better to historic control and from 1st to the 4th case scenario. Significant improvement was also seen in patient interaction, utilizing NIHSS and ABCD2 score in decision making, indications and contraindications to thrombolytic, utilization of resources including CT & CTA, CT perfusion and MRI of brain, door to needle time and consulting Neurointerventionalist.
CONCLUSIONS: Simulation training using SP's is a superior teaching method in the management of AS/TIA and helps to manage real life patients better. Residents felt that this way of learning was superior to classroom didactics. Acute stroke simulation can be utilized for other time critical diagnoses- MI, seizure and Trauma. It may be a useful teaching tool for smaller hospitals where patient volume is low, in addition to being utilized as an annual competency test.
Authors/Disclosures
Gulshan Uppal, MD, FAAN (Freeman Neurology and Headache Clinic)
PRESENTER 		Dr. Uppal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Uppal has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Pfizer.
Divyajot Sandhu, MD, MBBS (Sanford Medical Center) Dr. Sandhu has nothing to disclose.
Anantha Vellipuram, MD Dr. Vellipuram has nothing to disclose.
No disclosure on file
No disclosure on file
Ashish Nanda, MD (SSM health Neurosciences) No disclosure on file
David V. Lardizabal, MD, FAAN (Charleston Area Medical Center) Dr. Lardizabal has nothing to disclose.
Niranjan N. Singh, MD, FAAN Dr. Singh has nothing to disclose.
Giancarlo Comi, MD (University Vita-Salute) Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aspen Healthcare. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Rewind.